Global Non-Invasive Cancer Detection Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 89
Published Date: 01 Oct 2024
Category: Service & Software
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
Non-invasive cancer testing is a technology that detects cancer by analyzing biomarkers in body fluids such as blood, urine, and saliva without surgery or tissue biopsy. Common non-invasive testing methods include liquid biopsy, genetic testing, and imaging technology, which can detect cancer-related DNA, RNA, proteins, or circulating tumor cells (CTCs) to detect cancer early or monitor disease progression. Non-invasive testing is more comfortable for patients and has lower risks, and is particularly suitable for cancer screening, treatment effect evaluation, and recurrence monitoring.
According to our (Global Info Research) latest study, the global Non-Invasive Cancer Detection market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Non-Invasive Cancer Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Non-Invasive Cancer Detection market size and forecasts, in consumption value ($ Million), 2019-2030
Global Non-Invasive Cancer Detection market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Non-Invasive Cancer Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Non-Invasive Cancer Detection market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Invasive Cancer Detection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Invasive Cancer Detection market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Trublood, Datar Cancer Genetics, Nucleix, miR Scientific, Owlstone Medical, bioAffinity Technologies, Nonacus, Amadix, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Non-Invasive Cancer Detection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Non-Invasive Cancer Detection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Imaging Test
Nuclear Medicine Test
Others
Market segment by Application
Prostate Cancer
Bladder Cancer
Pancreatic Cancer
Breast Cancer
Gastric Cancer
Others
Market segment by players, this report covers
Trublood
Datar Cancer Genetics
Nucleix
miR Scientific
Owlstone Medical
bioAffinity Technologies
Nonacus
Amadix
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Non-Invasive Cancer Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-Invasive Cancer Detection, with revenue, gross margin, and global market share of Non-Invasive Cancer Detection from 2019 to 2024.
Chapter 3, the Non-Invasive Cancer Detection competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Non-Invasive Cancer Detection market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Invasive Cancer Detection.
Chapter 13, to describe Non-Invasive Cancer Detection research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-Invasive Cancer Detection by Type
1.3.1 Overview: Global Non-Invasive Cancer Detection Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Non-Invasive Cancer Detection Consumption Value Market Share by Type in 2023
1.3.3 Imaging Test
1.3.4 Nuclear Medicine Test
1.3.5 Others
1.4 Global Non-Invasive Cancer Detection Market by Application
1.4.1 Overview: Global Non-Invasive Cancer Detection Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Prostate Cancer
1.4.3 Bladder Cancer
1.4.4 Pancreatic Cancer
1.4.5 Breast Cancer
1.4.6 Gastric Cancer
1.4.7 Others
1.5 Global Non-Invasive Cancer Detection Market Size & Forecast
1.6 Global Non-Invasive Cancer Detection Market Size and Forecast by Region
1.6.1 Global Non-Invasive Cancer Detection Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Non-Invasive Cancer Detection Market Size by Region, (2019-2030)
1.6.3 North America Non-Invasive Cancer Detection Market Size and Prospect (2019-2030)
1.6.4 Europe Non-Invasive Cancer Detection Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Non-Invasive Cancer Detection Market Size and Prospect (2019-2030)
1.6.6 South America Non-Invasive Cancer Detection Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Non-Invasive Cancer Detection Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Trublood
2.1.1 Trublood Details
2.1.2 Trublood Major Business
2.1.3 Trublood Non-Invasive Cancer Detection Product and Solutions
2.1.4 Trublood Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Trublood Recent Developments and Future Plans
2.2 Datar Cancer Genetics
2.2.1 Datar Cancer Genetics Details
2.2.2 Datar Cancer Genetics Major Business
2.2.3 Datar Cancer Genetics Non-Invasive Cancer Detection Product and Solutions
2.2.4 Datar Cancer Genetics Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Datar Cancer Genetics Recent Developments and Future Plans
2.3 Nucleix
2.3.1 Nucleix Details
2.3.2 Nucleix Major Business
2.3.3 Nucleix Non-Invasive Cancer Detection Product and Solutions
2.3.4 Nucleix Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Nucleix Recent Developments and Future Plans
2.4 miR Scientific
2.4.1 miR Scientific Details
2.4.2 miR Scientific Major Business
2.4.3 miR Scientific Non-Invasive Cancer Detection Product and Solutions
2.4.4 miR Scientific Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 miR Scientific Recent Developments and Future Plans
2.5 Owlstone Medical
2.5.1 Owlstone Medical Details
2.5.2 Owlstone Medical Major Business
2.5.3 Owlstone Medical Non-Invasive Cancer Detection Product and Solutions
2.5.4 Owlstone Medical Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Owlstone Medical Recent Developments and Future Plans
2.6 bioAffinity Technologies
2.6.1 bioAffinity Technologies Details
2.6.2 bioAffinity Technologies Major Business
2.6.3 bioAffinity Technologies Non-Invasive Cancer Detection Product and Solutions
2.6.4 bioAffinity Technologies Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 bioAffinity Technologies Recent Developments and Future Plans
2.7 Nonacus
2.7.1 Nonacus Details
2.7.2 Nonacus Major Business
2.7.3 Nonacus Non-Invasive Cancer Detection Product and Solutions
2.7.4 Nonacus Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Nonacus Recent Developments and Future Plans
2.8 Amadix
2.8.1 Amadix Details
2.8.2 Amadix Major Business
2.8.3 Amadix Non-Invasive Cancer Detection Product and Solutions
2.8.4 Amadix Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Amadix Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Non-Invasive Cancer Detection Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Non-Invasive Cancer Detection by Company Revenue
3.2.2 Top 3 Non-Invasive Cancer Detection Players Market Share in 2023
3.2.3 Top 6 Non-Invasive Cancer Detection Players Market Share in 2023
3.3 Non-Invasive Cancer Detection Market: Overall Company Footprint Analysis
3.3.1 Non-Invasive Cancer Detection Market: Region Footprint
3.3.2 Non-Invasive Cancer Detection Market: Company Product Type Footprint
3.3.3 Non-Invasive Cancer Detection Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Non-Invasive Cancer Detection Consumption Value and Market Share by Type (2019-2024)
4.2 Global Non-Invasive Cancer Detection Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Non-Invasive Cancer Detection Consumption Value Market Share by Application (2019-2024)
5.2 Global Non-Invasive Cancer Detection Market Forecast by Application (2025-2030)
6 North America
6.1 North America Non-Invasive Cancer Detection Consumption Value by Type (2019-2030)
6.2 North America Non-Invasive Cancer Detection Market Size by Application (2019-2030)
6.3 North America Non-Invasive Cancer Detection Market Size by Country
6.3.1 North America Non-Invasive Cancer Detection Consumption Value by Country (2019-2030)
6.3.2 United States Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
6.3.3 Canada Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
6.3.4 Mexico Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Non-Invasive Cancer Detection Consumption Value by Type (2019-2030)
7.2 Europe Non-Invasive Cancer Detection Consumption Value by Application (2019-2030)
7.3 Europe Non-Invasive Cancer Detection Market Size by Country
7.3.1 Europe Non-Invasive Cancer Detection Consumption Value by Country (2019-2030)
7.3.2 Germany Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
7.3.3 France Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
7.3.5 Russia Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
7.3.6 Italy Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Non-Invasive Cancer Detection Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Non-Invasive Cancer Detection Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Non-Invasive Cancer Detection Market Size by Region
8.3.1 Asia-Pacific Non-Invasive Cancer Detection Consumption Value by Region (2019-2030)
8.3.2 China Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
8.3.3 Japan Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
8.3.4 South Korea Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
8.3.5 India Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
8.3.7 Australia Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
9 South America
9.1 South America Non-Invasive Cancer Detection Consumption Value by Type (2019-2030)
9.2 South America Non-Invasive Cancer Detection Consumption Value by Application (2019-2030)
9.3 South America Non-Invasive Cancer Detection Market Size by Country
9.3.1 South America Non-Invasive Cancer Detection Consumption Value by Country (2019-2030)
9.3.2 Brazil Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
9.3.3 Argentina Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Non-Invasive Cancer Detection Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Non-Invasive Cancer Detection Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Non-Invasive Cancer Detection Market Size by Country
10.3.1 Middle East & Africa Non-Invasive Cancer Detection Consumption Value by Country (2019-2030)
10.3.2 Turkey Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
10.3.4 UAE Non-Invasive Cancer Detection Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Non-Invasive Cancer Detection Market Drivers
11.2 Non-Invasive Cancer Detection Market Restraints
11.3 Non-Invasive Cancer Detection Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Non-Invasive Cancer Detection Industry Chain
12.2 Non-Invasive Cancer Detection Upstream Analysis
12.3 Non-Invasive Cancer Detection Midstream Analysis
12.4 Non-Invasive Cancer Detection Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Non-Invasive Cancer Detection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Non-Invasive Cancer Detection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Non-Invasive Cancer Detection Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Non-Invasive Cancer Detection Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Trublood Company Information, Head Office, and Major Competitors
Table 6. Trublood Major Business
Table 7. Trublood Non-Invasive Cancer Detection Product and Solutions
Table 8. Trublood Non-Invasive Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Trublood Recent Developments and Future Plans
Table 10. Datar Cancer Genetics Company Information, Head Office, and Major Competitors
Table 11. Datar Cancer Genetics Major Business
Table 12. Datar Cancer Genetics Non-Invasive Cancer Detection Product and Solutions
Table 13. Datar Cancer Genetics Non-Invasive Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Datar Cancer Genetics Recent Developments and Future Plans
Table 15. Nucleix Company Information, Head Office, and Major Competitors
Table 16. Nucleix Major Business
Table 17. Nucleix Non-Invasive Cancer Detection Product and Solutions
Table 18. Nucleix Non-Invasive Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. miR Scientific Company Information, Head Office, and Major Competitors
Table 20. miR Scientific Major Business
Table 21. miR Scientific Non-Invasive Cancer Detection Product and Solutions
Table 22. miR Scientific Non-Invasive Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 23. miR Scientific Recent Developments and Future Plans
Table 24. Owlstone Medical Company Information, Head Office, and Major Competitors
Table 25. Owlstone Medical Major Business
Table 26. Owlstone Medical Non-Invasive Cancer Detection Product and Solutions
Table 27. Owlstone Medical Non-Invasive Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 28. Owlstone Medical Recent Developments and Future Plans
Table 29. bioAffinity Technologies Company Information, Head Office, and Major Competitors
Table 30. bioAffinity Technologies Major Business
Table 31. bioAffinity Technologies Non-Invasive Cancer Detection Product and Solutions
Table 32. bioAffinity Technologies Non-Invasive Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 33. bioAffinity Technologies Recent Developments and Future Plans
Table 34. Nonacus Company Information, Head Office, and Major Competitors
Table 35. Nonacus Major Business
Table 36. Nonacus Non-Invasive Cancer Detection Product and Solutions
Table 37. Nonacus Non-Invasive Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 38. Nonacus Recent Developments and Future Plans
Table 39. Amadix Company Information, Head Office, and Major Competitors
Table 40. Amadix Major Business
Table 41. Amadix Non-Invasive Cancer Detection Product and Solutions
Table 42. Amadix Non-Invasive Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 43. Amadix Recent Developments and Future Plans
Table 44. Global Non-Invasive Cancer Detection Revenue (USD Million) by Players (2019-2024)
Table 45. Global Non-Invasive Cancer Detection Revenue Share by Players (2019-2024)
Table 46. Breakdown of Non-Invasive Cancer Detection by Company Type (Tier 1, Tier 2, and Tier 3)
Table 47. Market Position of Players in Non-Invasive Cancer Detection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 48. Head Office of Key Non-Invasive Cancer Detection Players
Table 49. Non-Invasive Cancer Detection Market: Company Product Type Footprint
Table 50. Non-Invasive Cancer Detection Market: Company Product Application Footprint
Table 51. Non-Invasive Cancer Detection New Market Entrants and Barriers to Market Entry
Table 52. Non-Invasive Cancer Detection Mergers, Acquisition, Agreements, and Collaborations
Table 53. Global Non-Invasive Cancer Detection Consumption Value (USD Million) by Type (2019-2024)
Table 54. Global Non-Invasive Cancer Detection Consumption Value Share by Type (2019-2024)
Table 55. Global Non-Invasive Cancer Detection Consumption Value Forecast by Type (2025-2030)
Table 56. Global Non-Invasive Cancer Detection Consumption Value by Application (2019-2024)
Table 57. Global Non-Invasive Cancer Detection Consumption Value Forecast by Application (2025-2030)
Table 58. North America Non-Invasive Cancer Detection Consumption Value by Type (2019-2024) & (USD Million)
Table 59. North America Non-Invasive Cancer Detection Consumption Value by Type (2025-2030) & (USD Million)
Table 60. North America Non-Invasive Cancer Detection Consumption Value by Application (2019-2024) & (USD Million)
Table 61. North America Non-Invasive Cancer Detection Consumption Value by Application (2025-2030) & (USD Million)
Table 62. North America Non-Invasive Cancer Detection Consumption Value by Country (2019-2024) & (USD Million)
Table 63. North America Non-Invasive Cancer Detection Consumption Value by Country (2025-2030) & (USD Million)
Table 64. Europe Non-Invasive Cancer Detection Consumption Value by Type (2019-2024) & (USD Million)
Table 65. Europe Non-Invasive Cancer Detection Consumption Value by Type (2025-2030) & (USD Million)
Table 66. Europe Non-Invasive Cancer Detection Consumption Value by Application (2019-2024) & (USD Million)
Table 67. Europe Non-Invasive Cancer Detection Consumption Value by Application (2025-2030) & (USD Million)
Table 68. Europe Non-Invasive Cancer Detection Consumption Value by Country (2019-2024) & (USD Million)
Table 69. Europe Non-Invasive Cancer Detection Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Asia-Pacific Non-Invasive Cancer Detection Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Asia-Pacific Non-Invasive Cancer Detection Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Asia-Pacific Non-Invasive Cancer Detection Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Asia-Pacific Non-Invasive Cancer Detection Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Asia-Pacific Non-Invasive Cancer Detection Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Asia-Pacific Non-Invasive Cancer Detection Consumption Value by Region (2025-2030) & (USD Million)
Table 76. South America Non-Invasive Cancer Detection Consumption Value by Type (2019-2024) & (USD Million)
Table 77. South America Non-Invasive Cancer Detection Consumption Value by Type (2025-2030) & (USD Million)
Table 78. South America Non-Invasive Cancer Detection Consumption Value by Application (2019-2024) & (USD Million)
Table 79. South America Non-Invasive Cancer Detection Consumption Value by Application (2025-2030) & (USD Million)
Table 80. South America Non-Invasive Cancer Detection Consumption Value by Country (2019-2024) & (USD Million)
Table 81. South America Non-Invasive Cancer Detection Consumption Value by Country (2025-2030) & (USD Million)
Table 82. Middle East & Africa Non-Invasive Cancer Detection Consumption Value by Type (2019-2024) & (USD Million)
Table 83. Middle East & Africa Non-Invasive Cancer Detection Consumption Value by Type (2025-2030) & (USD Million)
Table 84. Middle East & Africa Non-Invasive Cancer Detection Consumption Value by Application (2019-2024) & (USD Million)
Table 85. Middle East & Africa Non-Invasive Cancer Detection Consumption Value by Application (2025-2030) & (USD Million)
Table 86. Middle East & Africa Non-Invasive Cancer Detection Consumption Value by Country (2019-2024) & (USD Million)
Table 87. Middle East & Africa Non-Invasive Cancer Detection Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Global Key Players of Non-Invasive Cancer Detection Upstream (Raw Materials)
Table 89. Global Non-Invasive Cancer Detection Typical Customers
List of Figures
Figure 1. Non-Invasive Cancer Detection Picture
Figure 2. Global Non-Invasive Cancer Detection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Non-Invasive Cancer Detection Consumption Value Market Share by Type in 2023
Figure 4. Imaging Test
Figure 5. Nuclear Medicine Test
Figure 6. Others
Figure 7. Global Non-Invasive Cancer Detection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Non-Invasive Cancer Detection Consumption Value Market Share by Application in 2023
Figure 9. Prostate Cancer Picture
Figure 10. Bladder Cancer Picture
Figure 11. Pancreatic Cancer Picture
Figure 12. Breast Cancer Picture
Figure 13. Gastric Cancer Picture
Figure 14. Others Picture
Figure 15. Global Non-Invasive Cancer Detection Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Non-Invasive Cancer Detection Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Market Non-Invasive Cancer Detection Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
Figure 18. Global Non-Invasive Cancer Detection Consumption Value Market Share by Region (2019-2030)
Figure 19. Global Non-Invasive Cancer Detection Consumption Value Market Share by Region in 2023
Figure 20. North America Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 21. Europe Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 22. Asia-Pacific Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 23. South America Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 24. Middle East & Africa Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 25. Company Three Recent Developments and Future Plans
Figure 26. Global Non-Invasive Cancer Detection Revenue Share by Players in 2023
Figure 27. Non-Invasive Cancer Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
Figure 28. Market Share of Non-Invasive Cancer Detection by Player Revenue in 2023
Figure 29. Top 3 Non-Invasive Cancer Detection Players Market Share in 2023
Figure 30. Top 6 Non-Invasive Cancer Detection Players Market Share in 2023
Figure 31. Global Non-Invasive Cancer Detection Consumption Value Share by Type (2019-2024)
Figure 32. Global Non-Invasive Cancer Detection Market Share Forecast by Type (2025-2030)
Figure 33. Global Non-Invasive Cancer Detection Consumption Value Share by Application (2019-2024)
Figure 34. Global Non-Invasive Cancer Detection Market Share Forecast by Application (2025-2030)
Figure 35. North America Non-Invasive Cancer Detection Consumption Value Market Share by Type (2019-2030)
Figure 36. North America Non-Invasive Cancer Detection Consumption Value Market Share by Application (2019-2030)
Figure 37. North America Non-Invasive Cancer Detection Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 39. Canada Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 40. Mexico Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 41. Europe Non-Invasive Cancer Detection Consumption Value Market Share by Type (2019-2030)
Figure 42. Europe Non-Invasive Cancer Detection Consumption Value Market Share by Application (2019-2030)
Figure 43. Europe Non-Invasive Cancer Detection Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 45. France Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Non-Invasive Cancer Detection Consumption Value Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Non-Invasive Cancer Detection Consumption Value Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Non-Invasive Cancer Detection Consumption Value Market Share by Region (2019-2030)
Figure 52. China Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 55. India Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Non-Invasive Cancer Detection Consumption Value Market Share by Type (2019-2030)
Figure 59. South America Non-Invasive Cancer Detection Consumption Value Market Share by Application (2019-2030)
Figure 60. South America Non-Invasive Cancer Detection Consumption Value Market Share by Country (2019-2030)
Figure 61. Brazil Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 62. Argentina Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 63. Middle East & Africa Non-Invasive Cancer Detection Consumption Value Market Share by Type (2019-2030)
Figure 64. Middle East & Africa Non-Invasive Cancer Detection Consumption Value Market Share by Application (2019-2030)
Figure 65. Middle East & Africa Non-Invasive Cancer Detection Consumption Value Market Share by Country (2019-2030)
Figure 66. Turkey Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 67. Saudi Arabia Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 68. UAE Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 69. Non-Invasive Cancer Detection Market Drivers
Figure 70. Non-Invasive Cancer Detection Market Restraints
Figure 71. Non-Invasive Cancer Detection Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Non-Invasive Cancer Detection Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Trublood Datar Cancer Genetics Nucleix miR Scientific Owlstone Medical bioAffinity Technologies Nonacus Amadix
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>